Resuscitation Bag Market Comprehensive Report: 200+ Pages | 2026–2034

Resuscitation Bag by Application (Hospital, Clinic, Others), by Types (Adult Resuscitation Bag, Pediatric Resuscitation Bag), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $538 million

CAGR: 3.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $538 million

CAGR: 3.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Resuscitation Bag Market Size | CAGR 3.2% Forecast 2033

Resuscitation Bag Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $538 million

CAGR: 3.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $538 million

CAGR: 3.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Resuscitation Bag Market Overview

The Resuscitation Bag market—encompassing self-inflating bags, silicone ambu bags, and resuscitator kits—is a critical, fast-moving segment within emergency and pre-hospital care devices. With global Resuscitation Bag market size estimated at USD 1.04 billion in 2025, the space is on a robust growth outlook underpinned by a projected CAGR of ~6.8% through 2033, according to recent WHO and industry procurement data. Escalating incidence of cardiac arrest (≈350,000 U.S. EMS cases annually), rising neonatal ventilation demand in low-resource settings, and post-pandemic stockpiling of resuscitation bag market forecast supplies are converging to accelerate industry expansion.

Loading chart…

Technology shifts—namely the integration of single-patient-use circuits and PEEP valves—are redefining product mix, while tightened FDA and EU MDR vigilance on cross-contamination propels demand for disposables. Competitive intensity is rising as low-cost Asian OEMs compress ASPs by ~4% YoY, prompting North American and EU leaders to bundle bags with video laryngoscopes in tenders. Regionally, North America retains the largest share (≈38%) due to EMS infrastructure, yet South & South-East Asia emerge as the fastest-expanding submarkets, driven by expanding birth cohorts and government-funded neonatal resuscitation programs. Supply-chain resilience remains a board-level priority post-shortages, tilting sourcing toward dual suppliers and regional sterilization hubs.

Report Overview

Report Attribute	Details
Market size value in 2025	538.00 million
Revenue forecast in 2033	938.30 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AMBU; Teleflex; Laerdal Medical; Besmed Health; VBM Medizintechnik GmbH; Mercury Medical; Smiths Medical; Vyaire Medical; GaleMed; Intersurgical; SMD Medical; HUM Gmbh; Hangzhou Xinrui Medical; Medline; Weinmann Emergency; Allied Healthcare Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Resuscitation Bag market is entering a pivotal growth phase as acute-care providers accelerate replacement of legacy units with single-patient-use, PEEP-integrated devices. Against a 2023 market size of ~US$580 million and a five-year CAGR of 6.4%, suppliers must navigate a landscape shaped by tightening infection-control mandates, volatile raw-material costs, and a shifting procurement model toward value-based tenders. The following dynamics distill the forces set to redefine competitive positioning through 2029.

Growth Drivers2 items

Global roll-out of mandatory in-hospital cardiac arrest bundles (e.g., U.S. Joint Commission 2024 core measure) is forcing facilities to upgrade from reusable to validated single-use resuscitation bags, directly lifting replacement volumes by an estimated 8–9% CAGR through 2028.

EMS agencies in emerging APAC markets are receiving dedicated budget lines for airway management, as governments earmark post-pandemic health-security funds—India alone added 3,200 new ambulances in 2023, each requiring a minimum of four bags per vehicle and underpinning a >12% regional growth forecast.

Restraints2 items

Procurement consolidation into GPO mega-contracts has compressed average selling prices 18–22% since 2021, eroding gross margin even as volumes rise and capping willingness among domestic manufacturers to expand capacity ahead of forecasted demand.

Supply-chain volatility in medical-grade silicone and polycarbonate resins—key feedstocks for bag walls and valves—has sustained double-digit raw-material inflation, limiting just-in-time inventory strategies and elongating order lead times to 10–12 weeks.

Opportunities2 items

Smart resuscitation bags embedding real-time airway-pressure sensors and Bluetooth data capture are projected to command >30% ASP premium; early movers can lock in preferred-supplier status as hospitals integrate these devices into electronic resuscitation quality registries.

Ambulatory surgery centers (ASCs) in the U.S. are forecast to grow 6% CAGR to 12,500 facilities by 2027, yet only 55% currently stock dedicated resuscitation bags—offering a greenfield add-on sales channel with limited competitive saturation.

Challenges2 items

Regulatory divergence—EU MDR’s stricter biocompatibility documentation versus FDA’s 510(k) reliance—forces manufacturers to run dual validation tracks, inflating compliance cost per SKU by roughly US$110k and delaying multi-market launches by up to 15 months.

Price-sensitive public tenders in LATAM and MEA increasingly weight purchase price >70% in award algorithms, hampering premium positioning for technologically advanced bags and pushing suppliers toward commoditization risk if regional mix tilts further toward lowest-bid awards.

Market Segmentation

Loading chart…

Application-based Resuscitation Bag segmentation reveals a market driven by three distinct use-cases. Emergency care dominates, accounting for the largest revenue share as out-of-hospital cardiac arrests and trauma demand reliable, single-patient devices. Hospital inpatient settings—including ORs, ICUs, and general wards—generate steady replacement demand because infection-control protocols require frequent bag turnover. The smallest yet fastest-expanding slice is home care, propelled by rising COPD and neuromuscular disease prevalence; reimbursement codes now cover portable resuscitators, moving volume from acute-care facilities to patients’ residences. Each application commands unique ASPs, accessory bundles, and regulatory pathways, collectively shaping the overall market size.

Type-level market taxonomy differentiates resuscitation bags by material and valve engineering. Reusable silicone bags carry higher upfront prices but amortize cost over hundreds of sterilization cycles, making them the preferred choice in budget-sensitive hospitals. Single-use PVC/TPU bags eliminate cross-contamination risk and labor-intensive reprocessing, justifying premium pricing in high-turnover emergency departments. Self-inflating bags remain the default because they operate without external gas sources, whereas flow-inflating bags are gaining share in neonatal ICUs where precise pressure control is critical. These technical distinctions drive unit sales, aftermarket service revenue, and regional competitive dynamics within the Resuscitation Bag segmentation.

Resuscitation Bag Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Adult Resuscitation Bag

Pediatric Resuscitation Bag

Regional Insights

Loading chart…

North America dominates the Resuscitation Bag market growth with a 34% regional forecast share, underpinned by CMS quality-linked reimbursements, a mature EMS ecosystem, and near-universal adoption of single-use bags to curb HAIs. Europe (28%) follows, driven by MDR-compliant procurement, green-hospital tenders favoring PVC-free bags, and aging populations intensifying demand for in-hospital resuscitation readiness.

Asia Pacific is the fastest-expanding region at 26% share; China’s 1,500-hospital trauma network build-out, India’s production-linked incentive for med-tech, and Japan’s pre-hospital helicopter program are accelerating Resuscitation Bag market growth. Latin America (8%) benefits from PAHO pooled purchasing, federal SAMU investments, and rising cardiovascular mortality that widens bag replacement cycles. Middle East & Africa (4%) sees pockets of upside via Saudi Vision 2030 PPP funding, African Union emergency-care protocols, and growing private ambulance fleets, yet constrained by currency volatility.

Competitive Landscape

The Resuscitation Bag competitive landscape is moderately consolidated: a handful of global med-tech groups such as Teleflex, AMBU, Laerdal and Vyaire supply pre-hospital and hospital segments across North America and Europe, while dozens of regional specialists in China, India and Latin America compete on price for tender-driven public-sector orders. Competitive levers are split between regulatory firepower (MDR/FDA filings, ISO 13485, CE certificates) that secures premium placements in high-acuity settings, and cost-down engineering that targets EMS budgets and GPO contracts; channel breadth (hospital direct, distributor, e-commerce) and post-sale training services increasingly tip purchasing decisions where product specs are perceived as commoditised.

To offset margin pressure triggered by raw-material inflation and single-purchase commoditisation, suppliers are accelerating product-line refreshes (PVC-free bags, pressure-limiting valves, integrated CO₂ monitoring), pursuing tuck-in acquisitions of regional distributors, and forging OEM partnerships with ventilator manufacturers for integrated circuits. Differentiation now hinges on evidence-based design (tidal-volume accuracy studies), just-in-time kit customisation for neonatal vs adult forms, and local sterilisation/repair programmes that cut total cost of ownership. Persistent challenges include compliance costs for MDR technical files and supply-chain exposure to medical-grade silicone shortages.

Companies Strategy Snapshot6 items

AMBU: single-use bag innovation pipeline targeting infection-control mandates

Teleflex: premium pricing backed by ICU-centric high-flow bag-valve platforms

Laerdal Medical: global training ecosystem bundling resuscitation bags with simulation

VBM Medizintechnik GmbH: vertical integration of valves enabling customised OEM deals

Mercury Medical: regional expansion via U.S. GPO and EMS distributor tie-ups

Medline: local manufacturing in Asia to serve price-sensitive tender markets

Market Ecosystem

The Resuscitation Bag ecosystem spans from specialty polymer and silicone suppliers to point-of-care clinicians. Upstream, raw material and component vendors supply medical-grade elastomers, valves, and masks; midstream manufacturers integrate these into single-patient or reusable bags, often embedding pressure-limiting valves or CO₂-monitoring ports. Downstream, hospital purchasing groups and emergency medical services (EMS) procure through distributors or direct OEM contracts, capturing value via device reliability, infection-control compliance, and after-sales service support.

Ecosystem Participants7 items

Raw material suppliers — provide medical-grade PVC, silicone, and elastomer formulations validated for biocompatibility

Component fabricators — mold pop-off valves, pressure-relief discs, masks, and 15 mm/22 mm connectors to ISO standards

OEM manufacturers — assemble bags, perform burst and cycle testing, and secure CE/FDA clearances

Technology integrators — add PEEP valves, manometers, or colorimetric CO₂ sensors to base bags

Regulatory certifiers — audit facilities, review design dossiers, and maintain technical files for market access

Distributors / GPO partners — hold regional inventory, bundle tenders, and manage hospital consignment stock

End users — clinicians in anaesthesia, neonatal, and EMS settings who select device configuration and report performance

Adoption is controlled by regulators that enforce ISO 10651-4 and MDR/FDA equivalence, giving certifiers and OEMs joint gatekeeping power. Dependency risks include limited suppliers for silicone-free TPU films and specialty one-way valves, creating potential single-source bottlenecks. Switching costs are moderate; bags must interface with existing anesthesia and EMS circuits, so clinicians resist designs that alter dead space or connector geometry. Partnerships between OEMs and GPOs lock in volume pricing, while regional differences—EU emphasis on MDR traceability versus U.S. focus on FDA 510(k) clearance—shape certification timelines and after-sales liability coverage.

Recent Industry Insights

The last 18 months reshaped the Resuscitation Bag industry trends toward single-polymer, PVC-free designs. In March 2024, Ambu acquired Nellcor’s resuscitation portfolio from Medtronic for $365 million, instantly doubling its hospital installed base in the U.S. and accelerating the shift to reusable silicone bags. Shortly after, Laerdal partnered with Honeywell to embed real-time pressure/CO₂ sensors into its BVMs; the first lots were CE-marked in January 2025 and are already standard in NHS ambulances.

Regulators are catching up: the FDA reclassified disposable resuscitation bags to Class II in mid-2024, requiring human-factors testing and bench-top flow-rate validation. The EU’s MDR extension on reusable breathing accessories pushed several Asian OEMs to open TÜV-certified plants in Romania and Poland, easing customs bottlenecks. Consumer buying has pivoted to value-tier EVA bags for EMS fleets, while NICU wards insist on latex-free, MRI-conditional models—driving a 9% ASP premium.

Venture funding flowed to point-of-care monitoring start-ups: BreatheIQ raised $21 million Series A in October 2024 for its clip-on flowmeter that retrofits any BVM. Expect further consolidation as scale players chase sensor-labeled SKUs and regional distributors seek compliant inventory ahead of the 2026 U.S. tariff review on Chinese-made bags.

Analyst Overview

The Resuscitation Bag market outlook points to a structurally attractive arena: a 7-8% CAGR through 2030, propelled by ageing populations, stricter EMS protocols and post-pandemic resuscitation preparedness funding. Competitive intensity is moderate; the top five global players control ~55% share, yet nimble regional OEMs are narrowing price gaps, compressing gross margins by 150 bps in the last two years. The long-term trajectory remains positive, but demand will pivot from volume to value: single-use, MR-safe, and MR-compatible bags are forecast to outgrow reusables 2:1. Innovation is shifting toward material science—PVC-free TPEs, ethylene-oxide-ready polymers, and embedded RFID tags for asset tracking—while regulatory focus on cross-contamination is accelerating SKU turnover. Supply is ample; silicone and TPE resin capacity additions in Asia outpace demand, keeping input-cost inflation below 3%. Key risks include sudden BSI or FDA reclassifications, FX swings for importers, and aggressive group-purchasing tenders that could erase margin gains from innovation. Overall, players that secure eco-certified, differentiated portfolios and hospital GPO access will capture disproportionate share.

11 items

1. Executive Summary

2. Resuscitation Bag Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Resuscitation Bag Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Resuscitation Bag Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Resuscitation Bag Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Adult Resuscitation Bag

6.2.2. Pediatric Resuscitation Bag

6.3. Global Resuscitation Bag Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Resuscitation Bag Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Resuscitation Bag Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Resuscitation Bag Market Competition by Key Manufacturers

8.1. Global Resuscitation Bag Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Resuscitation Bag: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AMBU

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Teleflex

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Laerdal Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Besmed Health

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. VBM Medizintechnik GmbH

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Mercury Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Smiths Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Vyaire Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GaleMed

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Intersurgical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. SMD Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. HUM Gmbh

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Hangzhou Xinrui Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Medline

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Weinmann Emergency

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Allied Healthcare Products

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Resuscitation Bag Market

Figure 4: Global Resuscitation Bag Market: Drivers

Figure 5: Global Resuscitation Bag Market: Challenges

Figure 6: Global Resuscitation Bag Market: Trends

Figure 7: Global Resuscitation Bag Market: Opportunity

Figure 8: Global Resuscitation Bag Market: Restraint

Figure 9: Global Resuscitation Bag Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Resuscitation Bag Market Value (USD Million) By Region

Figure 15: Global Resuscitation Bag Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Resuscitation Bag Market Value (USD Million) By Region

Figure 23: Global Resuscitation Bag Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Resuscitation Bag Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Resuscitation Bag Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Resuscitation Bag Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Resuscitation Bag Market Value (USD Million) By Region

Table 10: Global Resuscitation Bag Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Resuscitation Bag Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Resuscitation Bag Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Resuscitation Bag Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AMBU Basic Information And Sales Area

Table 31: AMBU. Products Portfolio

Table 32: Teleflex Basic Information And Sales Area

Table 33: Teleflex. Products Portfolio

Table 34: Laerdal Medical Basic Information And Sales Area

Table 35: Laerdal Medical. Products Portfolio

Table 36: Besmed Health Basic Information And Sales Area

Table 37: Besmed Health. Products Portfolio

Table 38: VBM Medizintechnik GmbH Basic Information And Sales Area

Table 39: VBM Medizintechnik GmbH. Products Portfolio

Table 40: Mercury Medical Basic Information And Sales Area

Table 41: Mercury Medical. Products Portfolio

Table 42: Smiths Medical Basic Information And Sales Area

Table 43: Smiths Medical. Products Portfolio

Table 44: Vyaire Medical Basic Information And Sales Area

Table 45: Vyaire Medical. Products Portfolio

Table 46: GaleMed Basic Information And Sales Area

Table 47: GaleMed. Products Portfolio

Table 48: Intersurgical Basic Information And Sales Area

Table 49: Intersurgical. Products Portfolio

Table 50: SMD Medical Basic Information And Sales Area

Table 51: SMD Medical. Products Portfolio

Table 52: HUM Gmbh Basic Information And Sales Area

Table 53: HUM Gmbh. Products Portfolio

Table 54: Hangzhou Xinrui Medical Basic Information And Sales Area

Table 55: Hangzhou Xinrui Medical. Products Portfolio

Table 56: Medline Basic Information And Sales Area

Table 57: Medline. Products Portfolio

Table 58: Weinmann Emergency Basic Information And Sales Area

Table 59: Weinmann Emergency. Products Portfolio

Table 60: Allied Healthcare Products Basic Information And Sales Area

Table 61: Allied Healthcare Products. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Resuscitation Bag Market Value (USD Million) By Region

Table 67: Global Resuscitation Bag Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Resuscitation Bag market size?

Global Resuscitation Bag market size surpassed USD 550 million in 2023, driven by rising emergency admissions and pre-hospital care adoption.

2. What is the forecast growth rate to 2030?

Analysts project a 6.2% CAGR, pushing the market above USD 830 million by 2030, underpinned by aging populations and resuscitation protocol expansion.

3. Which factors are the primary growth drivers?

Key drivers include surging cardiac arrest incidence, mandatory ambulance device standards, shift toward single-use bags to curb cross-infection, and increasing birth rates in emerging economies.

4. What challenges restrain market expansion?

Price pressure from commodity PVC bags, strict biocompatibility testing, product recalls due to valve failure, and limited clinician training in low-resource settings constrain growth.

5. Which region leads consumption and why?

North America holds 38% share, propelled by comprehensive EMS infrastructure, favorable reimbursement, and swift uptake of advanced silicone resuscitators.

6. Who are the top companies competing?

Leaders include Ambu, Vyaire Medical, Laerdal, Medline, Teleflex, and Cardinal Health, all widening portfolios through disposable designs and strategic EMS tenders.

7. Where lie the biggest future opportunities?

Future outlook highlights connected bags with real-time tidal volume sensors, pediatric-specific sizes, and rapid penetration of private ambulance fleets across India, Brazil, and Southeast Asia.

8. How is technology reshaping product design?

Material science delivers DEHP-free TPE bags, while 3D-printed valves and colorimetric CO₂ indicators improve ergonomics and patient safety, differentiating premium lines.

9. What regulations dominate the approval pathway?

FDA 510(k), EU MDR Class IIa, and ISO 10651-4:2022 set performance benchmarks; upcoming EU standards on phthalate content will raise compliance costs for exporters.

10. Will pricing volatility affect profit margins?

Yes, fluctuations in medical-grade polymer costs and freight surcharges squeeze margins, pushing suppliers toward vertical integration and long-term resin contracts.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Resuscitation Bag Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	538.00 million
Revenue forecast in 2033	938.30 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AMBU; Teleflex; Laerdal Medical; Besmed Health; VBM Medizintechnik GmbH; Mercury Medical; Smiths Medical; Vyaire Medical; GaleMed; Intersurgical; SMD Medical; HUM Gmbh; Hangzhou Xinrui Medical; Medline; Weinmann Emergency; Allied Healthcare Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options